US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Prestige Consumer Healthcare Inc. Common Stock (NY:PBH)

46.44 +0.84 (+1.84%)
Official Closing Price Updated: 6:30 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prestige Consumer Healthcare Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Beyond The Numbers: 4 Analysts Discuss Prestige Consumer Stock ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 21, 2025 ↗
 
Via Benzinga
News headline image
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For February 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 8, 2024 ↗
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
News headline image
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗
 
Via Benzinga
News headline image
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday ↗
 
Via Benzinga
News headline image
PBH Stock Earnings: Prestige Consumer Misses EPS, Misses Revenue for Q4 2024 ↗
PBH stock results show that Prestige Consumer missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art... 
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 15, 2024 ↗
Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million. 
Via Benzinga
News headline image
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Healthcare Sector Stocks: Consistent Above-Average Growth And Income ↗
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
News headline image
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
News headline image
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >